Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium apicoplast ribosome 50S subunit is an essential ribonucleoprotein complex located within the apicoplast, a unique four-membrane organelle of endosymbiotic origin found in malaria-causing parasites (Lim & McFadden, 2010). It functions alongside the 30S subunit to translate the 35-kb circular genome of the apicoplast, which encodes several ribosomal proteins and RNAs necessary for the organelle's maintenance and metabolic functions (Wilson et al., 1996). Because the apicoplast ribosome is phylogenetically related to bacterial ribosomes, it is susceptible to various antibiotics that do not affect the host's eukaryotic 80S ribosomes, providing a high degree of selective toxicity (Dahl & Rosenthal, 2007). Inhibitors such as clindamycin and azithromycin bind to the 50S subunit, specifically the 23S rRNA, to block peptide bond formation or translocation (Goodman et al., 2007). This inhibition leads to a characteristic delayed death phenotype, where the parasite completes its current intraerythrocytic cycle but fails to establish a productive infection in the subsequent generation of host cells (Botté et al., 2012). Consequently, this target is a major focus for the development of slow-acting but highly specific antimalarial therapies, often used in combination with faster-acting drugs.
Inhibition of protein translation by binding to the 23S rRNA or ribosomal proteins of the 50S subunit, preventing peptide bond formation or translocation, ultimately leading to the delayed death of the parasite (Goodman et al., 2007; Dahl & Rosenthal, 2007).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium apicoplast ribosome 50S subunit (Apicoplast 50S ribosome).